Abstract:Chiral benzoins are versatile precursors to various valuable synthons such as chiral hydrobenzoins and chiral vicinal amino alcohols. In principle, ketoreductase (KRED)-catalyzed asymmetric reduction of benzils could be one of the most straightforward, green, and stereoselective methods for the synthesis of chiral benzoins. Nevertheless, the practical application potential of this appealing approach has been hampered by the low substrate loadings (usually <10 g/L) and unsatisfactory catalytic efficiency reported to date. In the present work, through enzyme screening, wild-type (WT) ketoreductase SSCR was revealed to possess a decent specific activity of 69.8 U/mg against the unsubstituted benzil molecule 1a. Aided by structure-guided semirational protein engineering including alanine-scanning and site-saturation mutagenesis, SSCRQ245G, a variant of SSCR, was evolved with 5.0-fold improvement in specific activity (350.5 U/mg) and 7.0-fold enhancement in catalytic efficiency (1131 s(-1)mM(-1)), compared with the WT. By using SSCRQ245G as the reductase and employing glucose dehydrogenase (GDH) for the regeneration of nicotinamide adenine dinucleotide phosphate (NADPH), gratifyingly, as high as 100 g/L of 1a was completely reduced in a 5-gram-scale reaction, with the desired benzoin (S)-2a obtained in 96% isolated yield with 99% ee. Our developed biocatalytic synthesis also features a good space-time yield of 233 gL-1day(-1) and a decent E-factor of 44 (including water). Moreover, a three-step transformation of such biosynthesized benzoin (S)-2a into a synthetically useful chiral vicinal amino alcohol ligand 5 was realized in 64% overall yield. Finally, the synthetic potential of SSCRQ245G was further underscored by the smooth reduction of 16 other symmetrical and unsymmetrical benzils, delivering the corresponding chiral benzoins in 57-93% isolated yields with mostly good-to-excellent stereoselectivities (up to >99% ee). The current study not only provides efficient and sustainable access to chiral benzoins but also highlights the synthetic versatility of engineered ketoreductase-catalyzed stereoselective reduction of prochiral ketones.

Engineering Imine Reductase for Efficient Biosynthesis of 1-Aryl-Tetrahydro-β-Carbolines and Their N-Methylation Products

Chemoselective 1,2-Reduction and Regiodivergent Deuteration of Chromium-Bound Arenes

Asymmetric Synthesis of Sterically Hindered 1-Substituted Tetrahydro-β-carbolines Enabled by Imine Reductase: Enzyme Discovery, Protein Engineering, and Reaction Development

Asymmetric Synthesis of Bulky N-Cyclopropylmethyl-1-aryl-1-phenylmethylamines Catalyzed by Engineered Imine Reductases.

Semi-rational Design of Carbonyl Reductase Cat for Synthesis of (R)-Lipoic Acid Precursor

Computational Design of an Imine Reductase: Mechanism-Guided Stereoselectivity Reversion and Interface Stabilization

Biocatalytic Desymmetrization for the Atroposelective Synthesis of Axially Chiral Biaryls Using an Engineered Imine Reductase

Rational Engineering of Mesorhizobium Imine Reductase for Improved Synthesis of N-Benzyl Cyclo-tertiary Amines

Tuning an Imine Reductase for the Asymmetric Synthesis of Azacycloalkylamines by Concise Structure‐Guided Engineering

Imine Reductases: Multifunctional Biocatalysts with Varying Active Sites and Catalytic Mechanisms

Engineering a Carbonyl Reductase as a Potential Tool for the Synthesis of Chiral α‐Tetralinols

Semi-rational Engineering of Carbonyl Reductase YueD for Efficient Biosynthesis of Halogenated Alcohols with in Situ Cofactor Regeneration

Actinomycetes-derived imine reductases with a preference towards bulky amine substrates

Biocatalytic Synthesis of Ruxolitinib Intermediate via Engineered Imine Reductase

Engineered Imine Reductase for Larotrectinib Intermediate Manufacture

Atroposelective Synthesis of Axial Biaryls by Dynamic Kinetic Resolution Using Engineered Imine Reductases

Ni-Catalyzed Asymmetric Reductive Arylation of ⍺-Substituted Imides

One-Pot Cascade Synthesis of Mono- and Disubstituted Piperidines and Pyrrolidines using Carboxylic Acid Reductase (CAR), ω-Transaminase (ω-TA), and Imine Reductase (IRED) Biocatalysts

Asymmetric Synthesis of Chiral Benzoins Enabled by Engineered Ketoreductase-Catalyzed Stereoselective Reduction of Benzils

Synthesis of Substituted Acyclic and Cyclic N-Alkylhydrazines by Enzymatic Reductive Hydrazinations

Stereocomplementary Synthesis of β‐Aryl Propanamines by Enzymatic Dynamic Kinetic Resolution‐Reductive Amination